Your browser is no longer supported. Please, upgrade your browser.
Settings
EBIO Sesen Bio, Inc. daily Stock Chart
EBIO [NASD]
Sesen Bio, Inc.
Index- P/E- EPS (ttm)-1.11 Insider Own9.42% Shs Outstand47.79M Perf Week16.25%
Market Cap157.23M Forward P/E- EPS next Y-0.61 Insider Trans0.00% Shs Float11.36M Perf Month119.33%
Income- PEG- EPS next Q-0.13 Inst Own31.60% Short Float39.94% Perf Quarter265.56%
Sales0.43M P/S369.95 EPS this Y53.20% Inst Trans- Short Ratio1.16 Perf Half Y383.82%
Book/sh0.52 P/B6.33 EPS next Y-17.30% ROA- Target Price2.00 Perf Year100.61%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.62 - 3.50 Perf YTD305.67%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-6.00% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low430.56% ATR0.33
Employees17 Current Ratio- Sales Q/Q-100.00% Oper. Margin- RSI (14)69.43 Volatility13.01% 14.18%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume4.26 Prev Close3.29
ShortableNo LT Debt/Eq- EarningsMay 10 Payout- Avg Volume3.91M Price3.29
Recom2.00 SMA2023.92% SMA5082.39% SMA200167.56% Volume0 Change0.00%
Jan-19-16Downgrade Leerink Partners Outperform → Mkt Perform
May-19-15Reiterated Leerink Partners Outperform $23 → $6
May-18-18 07:30AM  Blog Exposure - ADMA Biologics Received US Patent for Treating Respiratory Infections ACCESSWIRE
May-17-18 08:00AM  Todays Research Reports on Stocks to Watch: Eleven Biotherapeutics and VIVUS ACCESSWIRE
May-16-18 06:30AM  Eleven Biotherapeutics Announces Corporate Name Change to Sesen Bio Business Wire +24.15%
May-15-18 04:05PM  Eleven Biotherapeutics Reports First Quarter Financial Results and Pipeline Updates Business Wire -5.69%
May-03-18 08:36AM  Implied Volatility Surging for Eleven Biotherapeutics (EBIO) Stock Options Zacks
08:20AM  Todays Research Reports on Stocks to Watch: Midatech Pharma and Eleven Biotherapeutics ACCESSWIRE
May-01-18 07:50AM  Market Trends Toward New Normal in Emerge Energy Services LP, NACCO Industries, 8x8, Eleven Biotherapeutics, Monolithic Power, and Highwoods Properties Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Apr-23-18 08:30AM  Today's Research Reports on Trending Tickers: Eleven Biotherapeutics and CVS Health ACCESSWIRE +9.42%
Apr-22-18 08:26AM  Who Are The Largest Shareholders In Eleven Biotherapeutics Inc (NASDAQ:EBIO)? Simply Wall St.
Apr-20-18 08:39AM  Eleven Biotherapeutics (EBIO) in Focus: Stock Moves 8.7% Higher Zacks +17.90%
08:00AM  With FDA Filing On The Horizon, NMTC Could Pull an EBIO-Like Move ACCESSWIRE
Apr-12-18 06:30AM  New Preclinical Data Highlighting Eleven Biotherapeutics DeBouganin Program to be Presented at 2018 AACR Annual Meeting Business Wire
Apr-04-18 04:05PM  Eleven Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Operating Results and Vicinium Development Progress Business Wire +12.80%
Apr-03-18 08:30AM  Preliminary Data from Phase 3 VISTA Trial in Bladder Cancer to Be Presented in a Plenary Session at American Urological Association Annual Meeting Business Wire +20.19%
Mar-21-18 09:20AM  Eleven Biotherapeutics Announces Pricing of $10.0 Million Offering Priced At-the-Market Business Wire -6.19%
Mar-20-18 12:52PM  For Eleven Biotherapeutics, Cancer Trial Outcomes Could Be 'Major Catalyst' Benzinga +7.62%
Mar-12-18 06:30AM  Enrollment Completed in Phase 3 Registration Trial for Non-Muscle Invasive Bladder Cancer Business Wire -10.40%
Mar-05-18 06:30AM  Eleven Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care Conference Business Wire +5.26%
Mar-02-18 08:20AM  New Research Coverage Highlights Eleven Biotherapeutics, Enova International, Veracyte, Ameris, Veritiv, and United Fire Group Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Feb-08-18 08:00AM  Eleven Biotherapeutics to Present at 2018 BIO CEO & Investor Conference GlobeNewswire
Jan-24-18 03:12PM  Eleven Biotherapeutics Appoints Richard Fitzgerald as Chief Financial Officer Business Wire
Jan-08-18 07:40AM  New Research Coverage Highlights ConnectOne, Rockwell Medical, Accelerate Diagnostics, Eleven Biotherapeutics, Renasant, and Natera Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Jan-02-18 04:30PM  Eleven Biotherapeutics to Present at Biotech Showcase 2018 Business Wire
Dec-13-17 07:00AM  Eleven Biotherapeutics Announces Chief Scientific Officer to Chair a Session at the Antibody Engineering and Therapeutics Meeting Business Wire
Dec-01-17 07:20AM  Wired News Idera Pharma Gets Fast Track Designation for IMO-2125 in Combination with Ipilimumab for Treatment of PD-1 Refractory Metastatic Melanoma ACCESSWIRE
Nov-30-17 04:30PM  Eleven Biotherapeutics to Present at the LD Micro Main Event 2017 Business Wire
Nov-22-17 06:55PM  Edited Transcript of EBIO earnings conference call or presentation 14-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-20-17 11:07AM  Eleven Biotherapeutics, Inc.: Sudden move in price, will it continue? Capital Cube -7.38%
08:30AM  Eleven Biotherapeutics Reports Third Quarter 2017 Financial Results Business Wire
08:00AM  Todays Research Reports on Stocks to Watch: Eleven Biotherapeutics and CytRx Corporation ACCESSWIRE
Nov-14-17 12:00PM  Eleven Biotherapeutics, Inc. to Host Earnings Call ACCESSWIRE
Nov-09-17 04:30PM  Eleven Biotherapeutics to Report Third Quarter 2017 Financial Results on November 14, 2017 Business Wire
08:00AM  Eleven Biotherapeutics to Present at Stifel 2017 Healthcare Conference Business Wire
Nov-03-17 04:31PM  Eleven Biotherapeutics Announces Closing of $8.0 Million Underwritten Public Offering Business Wire +5.56%
Nov-01-17 09:34AM  Eleven Biotherapeutics Prices of $8.0 Million Underwritten Public Offering Business Wire -22.11%
Oct-13-17 04:30PM  Eleven Biotherapeutics Appoints Richard Fitzgerald as Interim Chief Financial Officer Business Wire
Sep-22-17 08:00AM  Eleven Biotherapeutics Announces Completion of Vicinium Manufacturing for Ongoing Clinical Trials in Non-Muscle Invasive Bladder Cancer Business Wire
Sep-05-17 08:00AM  Eleven Biotherapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference Business Wire
Aug-16-17 10:10PM  Edited Transcript of EBIO earnings conference call or presentation 14-Aug-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-14-17 07:00AM  Eleven Biotherapeutics Reports Second Quarter 2017 Financial Results Business Wire -8.97%
06:00AM  Investor Network: Eleven Biotherapeutics, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-17 08:00AM  Eleven Biotherapeutics to Report Second Quarter 2017 Financial Results on Monday, August 14, 2017 Business Wire
Aug-03-17 04:05PM  Eleven Biotherapeutics to Present at Canaccord Genuity 37th Annual Growth Conference Business Wire
Jul-13-17 03:52PM  ETFs with exposure to Eleven Biotherapeutics, Inc. : July 13, 2017 Capital Cube
Jun-12-17 08:00AM  Eleven Biotherapeutics to Present at 2017 Marcum MicroCap Conference Business Wire
Jun-06-17 08:00AM  Eleven Biotherapeutics to Collaborate with AstraZeneca and the National Cancer Institute on Development of ViciniumTM in Combination with Durvalumab for the Treatment of Non-Muscle Invasive Bladder Cancer Business Wire
Jun-01-17 08:00AM  Eleven Biotherapeutics Announces Data and Safety Monitoring Board (DSMB) Recommendation to Continue Phase 3 Registration Trial with Vicinium in Non-Muscle Invasive Bladder Cancer Based on Review of Safety and Efficacy Data Business Wire +5.84%
May-26-17 01:05PM  ETFs with exposure to Eleven Biotherapeutics, Inc. : May 26, 2017 Capital Cube
12:01PM  Eleven Biotherapeutics, Inc.: Fading performance but may be making a comeback? Capital Cube
May-17-17 08:00AM  Eleven Biotherapeutics Continues Expansion of Clinical Development Team with Appointment of David Brooks, M.D., Ph.D., to Senior Vice President, Clinical Development Business Wire -7.32%
May-15-17 03:36PM  ETFs with exposure to Eleven Biotherapeutics, Inc. : May 15, 2017 Capital Cube
May-08-17 11:16AM  Eleven Biotherapeutics, Inc. :EBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 8, 2017 Capital Cube
May-04-17 07:00AM  Investor Network: Eleven Biotherapeutics, Inc. to Host Earnings Call Accesswire
07:00AM  Eleven Biotherapeutics Reports First Quarter 2017 Financial Results Business Wire
May-03-17 03:51PM  ETFs with exposure to Eleven Biotherapeutics, Inc. : May 3, 2017 Capital Cube
Apr-28-17 08:00AM  Eleven Biotherapeutics to Report First Quarter 2017 Financial Results on Thursday, May 4, 2017 Business Wire
Apr-21-17 02:53PM  ETFs with exposure to Eleven Biotherapeutics, Inc. : April 21, 2017 Capital Cube
Apr-03-17 08:01AM  ELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Apr-02-17 01:00PM  Eleven Biotherapeutics Presents New Preclinical Data at AACR Supporting the Potential of the Companys Locally- and Systematically-Administered Drug Candidates Business Wire
Mar-30-17 01:04PM  ELEVEN BIOTHERAPEUTICS, INC. Financials
Mar-28-17 09:10AM  Eleven Biotherapeutics, Inc. :EBIO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017 Capital Cube
09:10AM  Eleven Biotherapeutics, Inc. :EBIO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017
Mar-27-17 07:00AM  Eleven Biotherapeutics to Present New Preclinical Data at the American Association for Cancer Research Annual Meeting 2017 Business Wire +7.46%
Mar-24-17 07:31AM  ELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition +5.79%
07:07AM  Q4 2016 Eleven Biotherapeutics Inc Earnings Release - Time Not Supplied
07:00AM  Eleven Biotherapeutics Reports Fourth Quarter and Full Year 2016 Financial Results Business Wire
Mar-22-17 08:00AM  Eleven Biotherapeutics to Report Fourth Quarter and Full Year 2016 Financial Results on Friday, March 24, 2017 Business Wire
Mar-20-17 08:00AM  Eleven Biotherapeutics to Present at Oppenheimer's 27th Annual Healthcare Conference Business Wire
Mar-06-17 05:02PM  ELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-01-17 08:00AM  Eleven Biotherapeutics to Present at Upcoming Investor Conferences in March Business Wire
Feb-07-17 08:00AM  Eleven Biotherapeutics to Present at the 2017 BIO CEO & Investor Conference Business Wire
Jan-06-17 04:34PM  ELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events +6.48%
Dec-06-16 04:38PM  ELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Stat
Nov-29-16 11:05AM  Eleven Biotherapeutics, Inc. :EBIO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016 Capital Cube
11:05AM  Eleven Biotherapeutics, Inc. :EBIO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
Nov-15-16 09:51AM  Eleven Biotherapeutics 3Q Net Beats Street (EBIO) at Investopedia -14.04%
Nov-14-16 01:54PM  ETF Outlook: Winners and Losers In a Trump Presidency +11.45%
08:30AM  Eleven Biotherapeutics Inc Earnings Call scheduled for 8:30 am ET today
07:45AM  ELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:07AM  Q3 2016 Eleven Biotherapeutics Inc Earnings Release - Before Market Open
07:00AM  Eleven Biotherapeutics Reports Third Quarter 2016 Financial Results Business Wire
Nov-11-16 01:26PM  These 5 Stocks Under $10 Could Make You a Lot of Money -5.76%
Nov-04-16 04:01PM  Eleven Biotherapeutics to Report Third Quarter 2016 Financial Results on November 14, 2016 Business Wire +19.15%
Oct-31-16 04:10PM  Venture firm Third Rock raises $616M fund, names female partner at bizjournals.com -14.56%
Oct-19-16 05:05PM  ELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement -8.61%
Sep-25-16 10:35AM  5 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Sep-21-16 09:08PM  Eleven Biotherapeutics Acquires Viventia Bio at Investopedia
04:01PM  Eleven Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
12:49PM  Eleven Biotherapeutics (EBIO) Stock Increases, Buys Viventia Bio
10:20AM  Eleven Bio Finds Even More Pipeline Growth in M&A at 24/7 Wall St.
08:47AM  Eleven Biotherapeutics stock up 25% on news of Viventia Bio purchase at MarketWatch
07:11AM  ELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisitio
07:00AM  Eleven Biotherapeutics Acquires Viventia Bio to Create Targeted Protein Therapeutics Oncology Company Business Wire
Aug-25-16 09:38AM  4 stocks to watch at MarketWatch
Aug-19-16 04:13PM  ELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Change in Direct
Aug-17-16 09:29AM  Blog Coverage Eleven Biotherapeutics Hits Jackpot Grants Hoffmann-La Roche Exclusive Worldwide License
Aug-16-16 11:18AM  Eleven Biotherapeutics, Inc. :EBIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016
09:05AM  Can Eleven Biotherapeutics Keep Climbing With This Roche Deal? at 24/7 Wall St.
07:30AM  Eleven Biotherapeutics Completes Exclusive Licensing Deal for IL-6 Antagonist Antibody Technology, Including EBI-031 Business Wire
Aug-15-16 02:10PM  Movers and Shakers in Biotech: Global Blood Therapeutics Inc (GBT) and Eleven Biotherapeutics Inc (EBIO) at Insider Monkey +13.59%
Eleven Biotherapeutics, Inc., a biologic oncology company, focuses on the design and development of targeted protein therapeutics (TPTs). It develops products based on its proprietary TPT platform and focused on addressing areas of unmet medical needs in cancer. The company's lead product candidates include Vicinium that is in Phase 3 clinical trial in the United States and Canada for the treatment of non-muscle invasive bladder cancer; and Proxinium for use in treating squamous cell carcinoma of the head and neck. It is also developing systemically-administered TPTs, including VB6-845d for the treatment of multiple types of epithelial cell adhesion molecule positive solid tumors. Eleven Biotherapeutics, Inc. has a cooperative research and development agreement with the National Cancer Institute on the development of the company's targeted therapeutic, Vicinium in combination with AstraZeneca's immune checkpoint inhibitor, ImfinziTM (durvalumab), for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.